On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
John Steinberg and colleagues put healing durability in focus. A deep dive into topical oxygen, our remission work, and what the evidence can tell us about more ulcer-free time.
Marco Meloni and colleagues invite us to rethink “no-option” CLTI. Cell-therapy studies and LEGenD-1 suggest new possibilities, while longer ischemic remission remains a patient-centered hypothesis to test.
Congratulations to Stephen Twigg, Pete Lazzarini, Joel Lasschuit and the Australian team: their national foot registry shows how shared measurement can support better care—and why the U.S. and the world should build on this work.
A new Cleveland Clinic Perspective gives dedicated inpatient podiatry a practical framework: dependable toe-and-flow coordination, timely decisions, and a safer bridge from hospital to home.
A life-affirming Manchester celebration of my mentor, Professor Andrew J. M. Boulton: science, friendship, gratitude, and the work we carry forward.
A new 12-week randomized-trial meta-analysis finds higher diabetic foot ulcer closure with placental-derived CAMPs—while underscoring why product-, patient-, and system-specific evidence still matters.
Remembering USC Capital Campus’s April 2023 opening and the C2SHiP annual meeting and NSF/FDA interoperability workshop that followed in October, with the same spirit of collaboration still at work today.
A new multicenter randomized trial found 46% wound closure at 12 weeks with ovine forestomach matrix–hyaluronic acid plus standard care, versus 24% with standard care alone. The promise, the biology, the team, and the caveats.
Our shared work has passed 100,000 Google Scholar citations. A milestone for podiatric surgery, a thank-you to a worldwide team, and another opportunity to turn knowledge into more time living.
The Lancet’s three-part PAD Series connects diagnosis, treatment, and independence—including the companion review with Andrew Bradbury and Caitlin Hicks.
